But it's not exclusive to those taking GLP-1 drugs
They weren't shy about it
1 Introduction Prader-Willi syndrome (PWS) is a rare genetic disorder characterized by impaired hypothalamic development and function with an estimated incidence of 1 per 20,000 newborns ( Patients with PWS experience complex nutritional, neurodevelopmental, metabolic and behavioral changes that drive obesity development ( Obesity management in PWS typically includes a calorie-restricted diet, strict control of food access, regular physical activity and behavioral interventions ( 2 Case series 2.1 Patient 1 A 28-year-old female with PWS, resulting from uniparental disomy, was evaluated at our Endocrinology Unit
Indeed, matrix-embedded endothelial cells (MEECs) protect the healthy liver against acute ischemic injury
or more are the most likely to feel that there is a stigma attached to using GLP-1 medications for weight loss
Reduced caloric intake due to appetite suppression may lead to insufficient energy consumption, particularly during the initial treatment phase